Stage IA Testicular Cancer AJCC v8

specific

Stage III includes: Any pT/TX, Any N, M1, SX. TX: Testicular cancer in which the primary tumor cannot be assessed. M1: Testicular cancer with distant metastasis. SX: Marker studies not available or not performed. (AJCC 8th ed.)

33

Centers

33

Active Trials

—

Cancer Funding

Top Centers for Stage IA Testicular Cancer AJCC v8(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
NCI Comprehensive
Active Research Program
51.5
2
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
51.5
3
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
51.5
4
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
Active Research Program
51.5
5
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
51.5
6
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.5
7
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
51.5
8
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
51.5
9
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
51.5
10
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.5
11
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
51.5
12
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
51.5
13
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
51.5
14
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.5
15
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
Active Research Program
51.5
16
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
51.5
17
UCI Chao Family Comprehensive Cancer CenterOrange, CA
NCI Comprehensive
Active Research Program
51.5
18
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
51.5
19
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
51.5
20
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
51.5
21
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
51.5
22
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
51.5
23
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.5
24
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
Active Research Program
51.5
25
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
51.5
26
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
51.5
27
Cancer Center at IllinoisUrbana, IL
Active Research Program
51.5
28
The Jackson Laboratory Cancer CenterBar Harbor, ME
NCI Basic_laboratory
Active Research Program
51.5
29
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
51.5
30
Northwell Health Cancer InstituteNew York, NY
Active Research Program
51.5
31
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
51.5
32
Princess Margaret Cancer CentreToronto, ON
Active Research Program
51.5
33
BC CancerVancouver, BC
Active Research Program
51.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →